Persistent neuropsychiatric symptoms after acute COVID-19 recovery have been reported, including disturbances in sleep and mood. Patients who required hospitalization for COVID-19 may be at increased risk for post-acute psychological complications. This cross-sectional study aimed to quantify the prevalence of insomnia and examine its association with depressive symptoms among patients who had been hospitalized with COVID-19 and recovered for at least six months.
This was an analytical cross-sectional study conducted in 2023 at Shahid Beheshti Hospital in Zanjan, Iran. The work is reported as a medRxiv preprint and has not undergone peer review. The authors note that findings should not be used to guide clinical practice without further validation.
The study included 70 patients with PCR-confirmed COVID-19 who had been hospitalized and had recovered for a minimum of six months at the time of assessment. Participant information was obtained through review of medical records and telephone interviews. The sample size, inclusion criteria, and data collection methods are those reported by the authors.
Insomnia severity was assessed using the Insomnia Severity Index (ISI). Depressive symptoms were measured using the Beck Depression Inventory-II (BDI-II). The authors report aggregate scores and categorical thresholds for insomnia severity and depressive symptoms as applied in their analyses.
Descriptive statistics were used to summarize participant characteristics and scale scores. Associations between candidate variables and insomnia severity were examined using univariable linear regression, and a multivariable linear regression model was constructed to identify independent predictors of insomnia severity. Reported effect estimates include adjusted beta coefficients with 95% confidence intervals and p values where applicable.
The mean ISI score for the cohort was 8.06 ± 6.57. Overall, 40.0% of participants had at least subthreshold insomnia, and 17.1% met criteria for moderate to severe clinical insomnia. Regarding mood, 30.0% of participants exhibited some degree of depressive symptoms as measured by the BDI-II.
In univariable analyses, two factors were associated with greater insomnia severity: higher depressive symptom scores and lower educational level. In the multivariable linear regression model, depressive symptom severity remained an independent predictor of insomnia severity. The authors report that each one-point increase in BDI-II score corresponded to a 0.50-point increase in ISI score (adjusted β = 0.50; 95% CI: 0.34–0.66; p < 0.001).
The study received ethics approval from the Ethics Committee of Zanjan University of Medical Sciences (ethics code IR.ZUMS.REC.1401.194, approved 18 September 2022). The authors stated that participant consent procedures were followed and documented. Data produced in the study are not available to the public. This report is a preprint posted on medRxiv and has not been certified by peer review.
The authors conclude that insomnia and depressive symptoms were common among patients who had recovered from COVID-19 after hospitalization, and that depressive symptom severity was independently associated with greater insomnia severity. They suggest that routine screening for sleep disturbance and depressive symptoms may be beneficial in post-COVID follow-up care, particularly for patients who required hospitalization.
The source article is a brief preprint abstract and methods/results summary. Specific details that are not provided in the available source text include a full description of participant demographics, comorbid conditions, timing of assessments beyond the minimum 6-month recovery period, sample size justification or power calculation, the precise BDI-II score distribution or categorical cutpoints used, and any reported limitations or sensitivity analyses. Because these details were not reported in the source text, they are not included here.
Clinicians should interpret these results in the context of a small, single-center cross-sectional preprint study and await peer-reviewed confirmation or larger studies before changing practice.